|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-3-319-24097-8 |
003 |
DE-He213 |
005 |
20220115073625.0 |
007 |
cr nn 008mamaa |
008 |
160513s2016 sz | s |||| 0|eng d |
020 |
|
|
|a 9783319240978
|9 978-3-319-24097-8
|
024 |
7 |
|
|a 10.1007/978-3-319-24097-8
|2 doi
|
050 |
|
4 |
|a RE1-994
|
072 |
|
7 |
|a MJQ
|2 bicssc
|
072 |
|
7 |
|a MED063000
|2 bisacsh
|
072 |
|
7 |
|a MJQ
|2 thema
|
082 |
0 |
4 |
|a 617.7
|2 23
|
245 |
1 |
0 |
|a Anti-Angiogenic Therapy in Ophthalmology
|h [electronic resource] /
|c edited by Andreas Stahl.
|
250 |
|
|
|a 1st ed. 2016.
|
264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
300 |
|
|
|a X, 193 p. 26 illus., 23 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Essentials in Ophthalmology,
|x 2196-890X
|
505 |
0 |
|
|a Retinal Vascular Development -- Retinopathy of Prematurity -- Anti-Vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors -- AREDS Supplementation and the Progression Towards Neovascular Exudative AMD -- VEGF-Inhibition in Macular Telangiectasia Type 2 -- Diabetic Retinopathy -- Retinal Vein Occlusion -- Pharmacokinetics of Intravitreally Applied VEGF Inhibitors -- Neovascular Glaucoma -- Corneal Neovascular Diseases -- Anti‐Angiogenic Gene Therapy - Basic Science and Challenges for Translation into the Clinic.
|
520 |
|
|
|a This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.
|
650 |
|
0 |
|a Ophthalmology.
|
650 |
|
0 |
|a Blood-vessels-Diseases.
|
650 |
1 |
4 |
|a Ophthalmology.
|
650 |
2 |
4 |
|a Angiology.
|
700 |
1 |
|
|a Stahl, Andreas.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319240954
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319240961
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319795805
|
830 |
|
0 |
|a Essentials in Ophthalmology,
|x 2196-890X
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-3-319-24097-8
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|